
Outrun Therapeutics
Outrun Therapeutics is a preclinical biotech using E3 ligase inhibition to unlock the therapeutic potential of protein stabilisation for the treatment of cancer and other diseases.
Seed ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredApr 20, 2021 (5 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | undisclosed | — | fundraisingfox.com |
Timeline
- Website created
Founders and team
- SVSatpal Virdee foundersource: outruntx.com
Companies like Outrun Therapeutics
TTubulis$360M Series B+ · Oct 2025IInocras$31M Series B+ · Aug 2026
AAtavistik Bio$40M Series B+ · Mar 2026
CCamp4Series B+ · Jul 2022BBright Peak TherapeuticsSeries B+ · Aug 2026
HHotSpot Therapeutics$100M Series B+ · Nov 2021
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/outrun-therapeutics (get a free API key).